Cardiovascular and renal effects of atrial natriuretic factor

References

• Breuhaus B A, Saneii H H, Brandt M A, Chimoskey J E. Atriopeptin II lowers cardiac output in conscious sheep. Am J Physiol 1985; 249: R776–80
   PubMed Web of Science ®Google Scholar
• Lappe R W, Smits J FM, Todt J A, Debets J JM, Wendt R L. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ Res 1985; 56: 606–12
   PubMed Web of Science ®Google Scholar
• Currie M G, Geller D M, Cole B R, Boylan J G, Sheng W Y, Holmberg S W, Needleman P. Bioac-tive cardiac substances: Potent vasorelaxant activity in mammalian atria. Science 1983; 221: 71–3
   PubMed Web of Science ®Google Scholar
• Hiwatari M, Satoh K, Angus J A, Johnston C I. No effect of atrial natriuretic factor on cardiac rate, force and transmitter release. Clin Exp Pharmacol Physiol 1986; 13: 163–8
   PubMed Web of Science ®Google Scholar
• Bie P, Wang B C, Leadley R J, Jr, Goetz K L. Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs. Am J Physiol 1988; 254: R161–9
   PubMed Web of Science ®Google Scholar
• Almeida F A, Suzuki M, Maack T. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sci 1986; 39: 1193–9
   PubMed Web of Science ®Google Scholar
• Flückiger J P, Waeber B, Matsueda G, Delaloye B, Nussberger J, Brunner H R. Effect of atriopeptin III on hematocrit and volaemia of nephrectomized rats. Am J Physiol 1986; 251: H880–3
   PubMed Web of Science ®Google Scholar
• Groban L, Cowley A W, Ebert T J. Atrial natriuretic peptide augments forearm capillary filtration in humans. Am J Physiol 1990; 259: H258–3
   PubMed Web of Science ®Google Scholar
• Ilebekk A, Christensen G, Leistad E, Rutlen D L. Atrial natriuretic factor increases peritoneal fluid formation. Acta Physiol Scand, submitted
   Google Scholar
• O'Grady S M, Field M, Nash N T, Rao M C. Atrial natriuretic factor inhibits Na-K-Cl cotransport in teleost intestine. Am J Physiol 1985; 249: C531–4
   PubMed Web of Science ®Google Scholar
• Petritsch W, Holzer-Petsche U, Hinterleitner T, Krejs G J. Intravenous atrial natriuretic peptide does not affect water and ion transport in the human small intestine. Eur J Clin Invest 1989; 19: 272–7
   PubMed Web of Science ®Google Scholar
• Grotmol T, Buanes T, Christensen G. Atrial natriuretic factor (ANF) does not affect ion transport in human intestine but does in porcine intestine. Acta Physiol Scand 1993, in press
   PubMedGoogle Scholar
• Faber J E, Gettes D R, Gianturco D P. Microvascular effects of atrial natriuretic factor: Interaction with ar and a2-adrenoceptors. Circ Res 1988; 63: 415–28
   PubMed Web of Science ®Google Scholar
• Huxley V H, Tucker V L, Verburg K M, Freeman R H. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ Res 1987; 60: 304–7
   PubMed Web of Science ®Google Scholar
• Sarelius I H, Huxley V H. A direct effect of atrial peptide on arterioles of the terminal microvascula-ture. Am J Physiol 1990; 258: R1224–9
   PubMedGoogle Scholar
• Rutlen D L, Christensen G, Helgesen K G, Ilebekk A. Influence of atrial natriuretic factor on intravascular volume displacement in pigs. Am J Physiol 1990; 259: H1595–600
   PubMedGoogle Scholar
• Trippodo N C, Cole F E, Frohlich E D, MacPhee A A. Atrial natriuretic peptide decreases circulatory capacitance in areflexic rats. Circ Res 1986; 59: 291–6
   PubMed Web of Science ®Google Scholar
• Lee R W, Goldman S. Mechanism for decrease in cardiac output with atrial natriuretic peptide in dogs. Am J Physiol 1989; 256: H760–5
   PubMed Web of Science ®Google Scholar
• Chien Y W, Frohlich E D, Trippodo N C. Atrial natriuretic peptide increases resistane to venous return in rats. Am J Physiol 1987; 252: H894–9
   PubMed Web of Science ®Google Scholar
• Maack T. Atrial natriuretic factor: A physiological link between the heart and the kidney. Physio-logie. Gustav Fischer Verlag, aktuell, Stuttgart 1986; 59–85
   Google Scholar
• Marin-Grez M, Fleming J T, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 1986; 324: 473–6
   PubMed Web of Science ®Google Scholar
• Naess P A, Kirkeb0en K A, Christensen G, Kiil F. Inhibition of renal nitric oxide synthesis with N-monomethyl-L-arginine and NG-nitro-L-arginine. Am J Physiol, in press
   Google Scholar
• Maack T, Marion D N, Camargo M JF, Kleinert H D, Laragh J H, Vaughan E D, Atlas S A. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069–75
   PubMed Web of Science ®Google Scholar
• Fried T A, McCoy R N, Osgood R W, Stein J H. Effect of atriopeptin II on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus. Am J Physiol 1986; 250(Fl)119–22
   Google Scholar
• Sonnenberg H, Cupples W A, deBold A J, Veress A T. Intrarenal localization of the natriuretic effect on cardiac atrial extract. Can J Physiol Pharmacol 1982; 60: 1149–52
   PubMed Web of Science ®Google Scholar
• Sonnenberg H, Honrath U, Chong C K, Wilson D R. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986; 250: F963–6
   PubMed Web of Science ®Google Scholar
• Fried T A, Osgood R W, Stein J H. Tubular site(s) of action of atrial natriuretic peptide in the rat. Am J Physiol 1988; 255: F313–6
   PubMed Web of Science ®Google Scholar
• Gunning M E, Ballermann B J, Silva P, Brenner B M, Zeidel M L. Characterizaton of ANP receptors in rabbit inner medullary collecting duct cells. Am J Physiol 1988; 255: F324–30
   PubMedGoogle Scholar
• Chang M S, Lowe D G, Lewis M, Hellmiss R, Chen E, Goeddel D V. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 1989; 341: 68–72
   PubMed Web of Science ®Google Scholar
• Sosa R E, Volpe M, Marion D N, Glorioso N, Laragh J H, Vaughan E D, Jr, Maack T, Atlas S A. Effect of atrial natriuretic factor on renin secretion, plasma renin and aldosterone in dogs with acute unilateral renal artery cosntriction. J Hyper-tens Suppl 1985; 3: S299–302
   PubMedGoogle Scholar
• Villarreal D, Freeman R H, Davis J O, Verburg K M, Vari R C. Renal mechanisms for suppression of renin secretion by atrial natriuretic factor. Hypertension 1986; 8: 1128–35
   Web of Science ®Google Scholar
• Naess P A, Christensen G, Kiil F. Atrial natriuretic factor reduces renin release by opposing a-adrenoceptor activity. Am J Physiol 1991; 261: E240–5
   PubMed Web of Science ®Google Scholar
• Goetz K L. Evidence that atriopeptin is not a physiological regulator of sodium excretion. Hypertension 1990; 15: 9–19
   PubMed Web of Science ®Google Scholar
• Blaine E H. Atrial natriuretic factor plays a significant role in body fluid homeostasis. Hypertension 1990; 15: 2–8
   PubMed Web of Science ®Google Scholar
• Anderson J V, Donckier J, Payne N N, Beacham J, Slater J D, Bloom S R. Atrial natriuretic peptide: Evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci 1987; 72: 305–12
   PubMed Web of Science ®Google Scholar
• Seymour A A, Smith S G, Mazack E K. Effects of renal perfusion pressure on the natriuresis induced by atrial natriuretic factor. Am J Physiol 1987; 253: F234–8
   PubMed Web of Science ®Google Scholar
• Bie P, Wang B C, Leadley R J, Jr, Goetz K L. Enhanced atrial peptide natriuresis during angiotensin and aldosterone blockade in dogs. Am J Physiol 1990; 258: R1101–7
   PubMed Web of Science ®Google Scholar
• Koepke J P, Jones S, DiBona G F. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 1987; 252: R1019–23
   PubMedGoogle Scholar
• Tunny T J, Gordon R D. Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Banter's and Gordon's syndromes. Lancet 1986; i: 272–3
   Google Scholar
• Genest J, Larochelle P, Cusson J R, Gutkowska J, Cantin M. The atrial natriuretic factor in hypertension. State of the art lecture. Hypertension 1988; 11: 13–7
   Web of Science ®Google Scholar
• Widgren B R, Hedner T, Hedner J, Berglund G, Wikstrand J, Andersson O K. Resting and volume-stimulated circulating atrial natriuretic peptide in young normotensive men with positive family histories of hypertension. J Hypertens 1991; 9: 139–46
   PubMed Web of Science ®Google Scholar
• Ferrier C, Widmann P, Hollmann R, Dietler R, Shaw S. Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension. N Engl J Med 1988; 319: 1223–4
   PubMed Web of Science ®Google Scholar
• Dussaule J C, Ardaiilou R. Current indications of plasma atrial natriuretic peptide measurements in human diseases. Horm Res 1990; 34: 133–7
   PubMedGoogle Scholar
• Haass M, Dietz R, Fischer T A, Lang R E, Kubler W. Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy. Am J Cardiol 1988; 62: 764–70
   PubMed Web of Science ®Google Scholar
• Lee M E, Miller W L, Edwards B S, Burnett J C, Jr. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J CliInvest 1989; 84: 1962–6
   PubMed Web of Science ®Google Scholar
• Wood P. Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation. Br Heart J 1963; 25: 273–82
   PubMedGoogle Scholar
• Tikkanen I, Metsarinne K, Fyhrquist F. Atrial natriuretic peptide in paroxysmal supraventricular tachycardia. Lancet 1985; ii: 40–1
   Google Scholar
• Christensen G, Bugge J F, Ilebekk A, Kiil F. Atrial natriuretic factor induces natriuresis during pacing tachycardia in dogs. Am J Physiol 1989; 256: R1245–9
   PubMedGoogle Scholar
• Kojima S, Akabane S, Ohe T, Tsuchihashi K, Yamamoto K, Kuramochi M, Shimomura K, Ito K, Omae T. Plasma atrial natriuretic polypeptide and polyuria during paroxysmal tachycardia in Wolff-Parkinson-White syndrome patients. Nephron 1986; 44: 249–52
   PubMed Web of Science ®Google Scholar
• Walsh K P, Williams T D, Canepa-Anson R, Pitts E, Lightman S L, Sutton R. Effects of endogenous atrial natriuretic peptide released by rapid atrial pacing in dogs. Am J Physiol 1987; 253: R599–604
   PubMed Web of Science ®Google Scholar
• Miller W L, Edwards B S, Zimmerman R S, Burnett J C, Jr. Renal-endocrine adaptations to endogenous atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure. CirRes 1990; 66: 76–83
   PubMed Web of Science ®Google Scholar
• Berry A J. Respiratory support and renal function. Anesthesiology 1981; 55: 655–67
   PubMed Web of Science ®Google Scholar
• Kharasch E D, Yeo K T, Kenny M A, Buffington C W. Atrial natriuretic factor may mediate the renal effects of PEEP ventilation. Anesthesiology 1988; 69: 862–9
   PubMed Web of Science ®Google Scholar
• Leithner C, Frass M, Pacher R, Hartter E, Pesl H, Woloszczuk W. Mechanical ventilation with positive end-expiratory pressure decreases release of alpha-atrial natriuretic peptide. Crit Care Med 1987; 15: 484–8
   PubMed Web of Science ®Google Scholar
• Hevrey O, Klow N E, Forsdahl K, Mjø O D. Plasma concentrations of atrial natriuretic factor during positive end-expiratory pressure ventilation in dogs with normal or impaired left ventricular function. Acta Anaesthesiol Scand 1989; 33: 549–53
   PubMed Web of Science ®Google Scholar
• Christensen G, Bugge J F, Ostensen J, Kiil F. Atrial natriuretic factor and renal sodium excretion during ventilation with PEEP in hypervolemic dogs. J Appl Physiol 1992; 72: 993–7
   PubMed Web of Science ®Google Scholar
• Venus B, Mathru M, Smith R A, Pham C G, Shira-Kawa Y, Sugiura A. Renal function during application of positive end-expiratory pressure in swine: Effects of hydration. Anesthesiology 1985; 62: 765–9
   PubMed Web of Science ®Google Scholar
• Ellman H, Dembin H. Lack of adverse hemodynamic effects of PEEP in patients with acute respiratory failure. Crit Care Med 1982; 10: 706–11
   PubMed Web of Science ®Google Scholar
• Gnaedinger M P, Lang R E, Hasler L, Uehlinger D E, Shaw S, Weidmann P. Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man. Miner Electrolyte Metab 1986; 12: 371–4
   PubMedGoogle Scholar
• Maack T, Suzuki M, Almeida F A, Nussenzveig D, Scarborough R M, McEnroe G A, Lewicki J A. Physiological role of silent receptors of atrial natriuretic factor. Science 1987; 238: 675–8
   PubMed Web of Science ®Google Scholar
• Stephenson S L, Kenny A J. The hydrolysis of a-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopepti-dase-24.11. Biochem J 1987; 243: 183–7
   PubMed Web of Science ®Google Scholar
• Northridge D B, Jardine A G, Alabaster C T, Barclay P L, Connell J M, Dargie H J, Dilly S G, Findlay I N, Lever A F, Samuels G M. Effects of UK 69 578: A novel atriopeptidase inhibitor. Lancet 1989; ii: 591–3
   Google Scholar
• Seymour A A, Swerdel J N, Fennell S A, Druckman S P, Neubeck R, Delaney N G. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopep-tidase. J Cardiovasc Pharmacol 1989; 14: 194–204
   PubMed Web of Science ®Google Scholar
• Sybertz E J, Chiu P J, Vemulapalli S, Pitts B, Foster C J, Watkins R W, Barnett A, Haslanger M F. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological reesponses to atrial natriuretic factor and lowers blood pressure in desoxycorti-costerone acetate-sodium hypertensive rats. J Pharmacol Exp Ther 1989; 250: 624–31
   PubMed Web of Science ®Google Scholar
• Webb R L, Yasay G D, Jr., McMartin C, McNeal R B, Jr, Zimmerman M B. Degradation of atrial natriuretic peptide: Pharmacologic effects of protease EC 24.11 inhibition. J Cardiovasc Pharmacol 1989; 14: 285–93
   PubMed Web of Science ®Google Scholar